Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

In a milestone in mammalian genetic engineering, a team of researchers from the Chinese Academy of Sciences succeeded in ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Analysis of CRISPR/Cas9 edited cells is done to check the efficacy of the system in introducing mutations (insertions, deletions, or substitutions) in the DNA sequences of the edited cell population.

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Scientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...

A research group at Umeå University has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This research opens doors to new methods for ...

With vasa-Cas9, high efficiency and self-limiting suppression was achieved. Applying the CRISPR-Cas9 system to edit high GC content genomes has been challenging due to its high off-target activity.

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches -- gene therapy ...

Associate Professor Qing Zhong shared insights on AI breakthroughs in proteomics and multiomics, challenges in data sharing ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...